Biolexis Therapeutics has achieved a transformative milestone in metabolic drug discovery with the successful resolution of ...

While drug developers work to mitigate the side effects associated with GLP-1–based obesity drugs, recent studies reveal that ...

Coverage of GLP-1s is not necessarily in-your-face obvious. It leads to the conversation of whether we want to pursue weight ...

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Social support can improve the odds of successful weight loss. AnnaLee Canario and Dacia Benjamin say their friendship is the ...

Novo Nordisk and Eli Lilly currently control 99% of the market, but their dominance may weaken as new entrants introduce ...

Sienna Senior Living Inc. ("Sienna" or the "Company") today announced a dividend of $0.078 per common share of the Company (each, a "Common Share") for the month of March 2025, representing $0.936 per ...

Leading measurement and analytics company Adjust today released its annual Gaming App Insights 2025 report, showing a resilient gaming industry on the other side of a challenging 2023. Global gaming ...

Anti-obesity drugs are only part of the larger treatment plan for most patients. Exercise and nutrition are also keys.